Back to compounds

COMPOUND PROFILE / PEPTIDES & ANALOGUES

VIP / Vasoactive Intestinal Peptide.

Research draft

VIP is vasoactive intestinal peptide, an endogenous signalling peptide; synthetic VIP is also called aviptadil.

Keep the context.

Research evidence and COA results do not establish suitability for use. This is educational information, not a dosing guide or personal medical advice.

Targeted source and identity review, not a systematic review or complete regulatory audit.

Overview

VIP is vasoactive intestinal peptide, an endogenous signalling peptide; synthetic VIP is also called aviptadil.

CLASSIFICATIONPeptides & analogues
MOLECULAR / SEQUENCE INFONot specified
PRIMARY CONTEXTCompound

Mechanism

It activates VIP receptors affecting vascular tone, secretion and immune signalling.

Human research

Human physiological studies and disease trials exist. Outcomes are route- and disease-specific.

Preclinical & other research

Laboratory research explores immune and respiratory effects.

Safety & unknowns

Flushing, haemodynamic effects and other systemic responses matter; route-specific monitoring is important.

Regulatory status

Cross-link Aviptadil without counting the same trials twice; no general wellness indication is established.

Reported use & evidence

Research profile draft

The supplied VIP / Vasoactive Intestinal Peptide profile and its cited sources are imported. Community experiences and laboratory evidence remain separate from these descriptions. Missing evidence is not a zero result.

Sources & references

Explore more compounds